-
Examination of Attitudes Towards Vaccinations Among the Hungarian Population
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of RSVpreF Vaccine for RSV Prevention in Older Adults Under Situation of the National Vaccination Program in Taiwan: A Study on Economic and Clinical Advantages
Sep 9, 2025, 16:22 PM -
Comparative Prevalence of Suicidal Ideation and Self-Harm History: Rexulti vs. Other Oral Atypical Antipsychotics
Sep 9, 2025, 16:22 PM -
Patient Perspectives on Mild-Moderate Infection Burden in Multiple Myeloma and Chronic Lymphocytic/Small Lymphocytic Leukemia
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of Tenecteplase vs. Alteplase for Adults With Acute Ischemic Stroke (AIS) in Greece
Sep 9, 2025, 16:22 PM -
IMF: The Innovative Medicines Fund or the Interim Medicines Fund?
Sep 9, 2025, 16:22 PM -
Cross-Agency Analysis of Six-Minute Walk Test (6MWT) Adoption in Muscular and Nonmuscular Neurological HTA Submissions: Assessing Surrogate Endpoints for Disease Progression
Sep 9, 2025, 16:22 PM -
Factors Associated With the Publication of Real-World Evidence Studies in Lung Cancer by Journal Impact Factor
Sep 9, 2025, 16:22 PM -
Economic Burden of Generalized Myasthenia Gravis (gMG) in Latin America (LA): A Microcosting Analysis of Direct Medical Costs (DMCs)
Sep 9, 2025, 16:22 PM -
Assessment of the Economic and Societal Impact of Cervical Cancer Treatment in Bulgaria
Sep 9, 2025, 16:22 PM -
Work Complexity in Adults With Phenylketonuria in Sweden in 2020
Sep 9, 2025, 16:22 PM -
Mapping Access Pathways for New Medicines in Finland: A Real-World Review of HTA and Reimbursement Decisions
Sep 9, 2025, 16:22 PM -
Premature Cancer-Related Morbidity and Mortality in Israel: Years Lived With Disability and Years of Life Lost Productivity Costs
Sep 9, 2025, 16:22 PM -
Evaluating the Repurposing Potential of Statins: Association Between Statin Use and Cognitive Decline in Patients With Mild-to-Moderate Alzheimer’s Disease
Sep 9, 2025, 16:22 PM -
Using Social Media Listening to Understand Oncology-Specific Patient Experiences: A Comparison of Pharmaceutical Industry-Funded vs. Nonpharmaceutical Industry-Funded Studies
Sep 9, 2025, 16:22 PM -
Economic Evaluation of a Standardized Care Pathway for Nontraumatic Acute Abdominal Pain in the Emergency Department
Sep 9, 2025, 16:22 PM -
Survival Extrapolations With and Without Incorporating External Evidence: Evaluating the Performance of Bayesian M-Spline Models vs. Parametric Models in First-Line Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Sep 9, 2025, 16:22 PM -
Real-World Costs of United States Patients With T1 Diabetes, Removing Misdiagnosed Patients, and Compared With Patients With T1D and (T1.5 or T2) Diabetes
Sep 9, 2025, 16:22 PM -
Clinical Outcome Assessments in Drug Approvals: Trends and Insights From FDA; EMA Labeling 2018-2023
Sep 9, 2025, 16:22 PM -
Assessment of Real-World Effectiveness of Biologic Treatments for Moderate-to-Severe Atopic Dermatitis in Poland
Sep 9, 2025, 16:22 PM
